Carson Wealth (CWM LLC)
LXRX icon

Carson Wealth (CWM LLC)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.2K Sell
10,402
-2,777
-21% -$4.04K ﹤0.01% 4542
2025
Q4 		$15K Sell
13,179
-13,565
-51% -$18.6K ﹤0.01% 4334
2025
Q3 		$36K Sell
26,744
-82,586
-76% -$93.7K ﹤0.01% 3766
2025
Q2 		$103K Buy
109,330
+3,826
+4% +$2.48K ﹤0.01% 2695
2025
Q1 		$49K Buy
105,504
+104,373
+9,228% +$65.8K ﹤0.01% 3017
2024
Q4 		$1K Buy
1,131
+1,031
+1,031% +$1.24K ﹤0.01% 4741
2024
Q3 		$0 Buy
100
+33
+49% +$59 ﹤0.01% 5001
2024
Q2 		$0 Buy
67
+65
+3,250% +$117 ﹤0.01% 4778
2024
Q1 		$0 Buy
+2
New +$4 ﹤0.01% 4552
2023
Q3 		– Sell
-230
Closed -$1K – 4374
2023
Q2 		$1K Buy
+230
New +$611 ﹤0.01% 3996

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Carson Wealth (CWM LLC)'s LXRX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Lexicon Pharmaceuticals (LXRX) stake by 21% in Q1 2026, selling an estimated $4.04K and leaving 10,402 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4542.

Carson Wealth (CWM LLC) first reported a position in LXRX in Q2 2023 and has held it in 10 quarters since. The position peaked at $103K in Q2 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 10,402 shares of Lexicon Pharmaceuticals worth $16.2K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 2,777 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $4.04K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4542 holding.
  • Carson Wealth (CWM LLC) first reported a position in Lexicon Pharmaceuticals in Q2 2023 and has held it in 10 quarters since.
  • Carson Wealth (CWM LLC)'s Lexicon Pharmaceuticals position peaked at $103K in Q2 2025.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.